-
-
-
-
-
-
-
MediWound Strengthens European Presence of NexoBrid®
-
-
-
-
-
-
-
MediWound Announces a 1-for-7 Reverse Share Split
-
-
-
-
-
-
-
MediWound Reports Second Quarter 2022 Financial Results and Provides Company Updates
-
-
-
-
-
-
-
MediWound Announces Peer-Reviewed Paper of a Case Series Report of Basal Cell Carcinoma Published in the Open Dermatology Journal
-
-
-
-
-
-
-
MediWound Enrolls First Patient in Phase 2 Pharmacology Study of EscharEx
-
-
-
-
-
-
-
MediWound Reports Fourth Quarter and Full-Year 2020 Financial Results
-
-
-
-
-
-
-
MediWound to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
-
12,349 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All